News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal107d agoneutral
Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss AdsThe Wall Street Journal107d agoneutral
Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss AdsSimply Wall St.110d agoneutral
Novo Nordisk (CPSE:NOVO B) Stock Looks Reasonable On Earnings While Returns Stay WeakReuters Videos110d agoneutralVIDEO
Novo sues Lilly, claiming misleading ads in weight-loss drug battleInvestor's Business Daily110d agoneutral
Why Agios Pharma, A Novo Rival, Just Pulled A Bearish MoveThe Wall Street Journal110d agoneutral
Novo Nordisk Files Deceptive Advertising Lawsuit Against Rival Eli LillyReuters110d agoneutral
Novo Nordisk says it is suing Eli Lilly, accusing it of false advertisingFinancial Times110d agoneutral
Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss fightInvestor's Business Daily115d agoneutral
The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo?The Wall Street Journal117d agoneutral
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’sReuters122d agoneutral
India's Dr Reddy's on track for worst day in 3 years as semaglutide supplies hitInvestor's Business Daily124d agoneutral
Eli Lilly's Market Cap Balloons Again On This IPO's SetbackThe Wall Street Journal129d agoneutral
Why Medicare Isn’t a Game Changer for Weight-Loss Drugmakers